Vivaldi Biosciences
Vivaldi Biosciences is a biotechnology company developing live attenuated influenza vaccines founded in 2010 by Adolfo García-Sastre, Peter Palese and Elliott Kieff.
1
Funding Rounds
$2.0m
Money raised
Overview
Vivaldi Biosciences is a biotechnology company developing live attenuated influenza vaccines founded in 2010 by Adolfo García-Sastre, Peter Palese and Elliott Kieff.
- Website:
- Business model: B2B B2C
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ad**** Ga************ | - | - | - |
| Pe*** Pa**** | - | - | - |
| El***** Ki*** | - | - | - |
Funding series
Funding Series Analysis
The company Vivaldi Biosciences has raised a total of $2m in funding over 1 rounds.
Key Insights:
- Vivaldi Biosciences Series A round: $2m
Vivaldi Biosciences Series A round
$2m
Industries
Vivaldi Biosciences is active in the following industries: